E2F7 and breast carcinoma: Chu et al. reported that the overexpression of E2F7 in breast cancer can inhibit miR-15a/16 transcription, cause Cyclin E1 and Bcl-2 to participate in tumor invasion and metastasis, and increase the resistance of breast cancer cells to tamoxifen.[15]